IL-17A, IL-17F, IL-21, and IL-22 are significantly induced in MS patients compared to HCs at baseline, and upon stimulation with Th17-polarizing cytokines (Figures 4A,B), confirming preferential IL-1R-induced Th17 cell differentiation in RR MS. This evidence concerns the gene IL22 and myeloid sarcoma.